Rating History for Neumora Therapeutics (NMRA) by William Blair

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/17/2026 Myles R. Minter Upgrade Outperform
(Market Perform)
N/A
(N/A)
3.20
(1.61)
-49.69% Details